Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 8 | 2013 | 1204 | 0.910 |
Why?
|
Anxiety | 2 | 2011 | 287 | 0.680 |
Why?
|
Depression | 2 | 2013 | 473 | 0.650 |
Why?
|
Social Support | 2 | 2013 | 193 | 0.490 |
Why?
|
Adaptation, Psychological | 2 | 2013 | 157 | 0.480 |
Why?
|
Biotinylation | 1 | 2012 | 41 | 0.450 |
Why?
|
Self Efficacy | 1 | 2013 | 53 | 0.440 |
Why?
|
Depressive Disorder | 2 | 2013 | 218 | 0.440 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2012 | 90 | 0.430 |
Why?
|
Plasmids | 1 | 2012 | 287 | 0.420 |
Why?
|
Health Status | 2 | 2011 | 360 | 0.420 |
Why?
|
Simplexvirus | 1 | 2012 | 151 | 0.410 |
Why?
|
Patient Compliance | 1 | 2013 | 227 | 0.400 |
Why?
|
Activities of Daily Living | 1 | 2011 | 204 | 0.370 |
Why?
|
Stress, Psychological | 1 | 2011 | 313 | 0.320 |
Why?
|
Quality of Life | 2 | 2011 | 1585 | 0.280 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2016 | 165 | 0.230 |
Why?
|
Immediate-Early Proteins | 2 | 2016 | 164 | 0.230 |
Why?
|
Heart Transplantation | 3 | 2005 | 705 | 0.220 |
Why?
|
Coronary Disease | 9 | 1994 | 261 | 0.200 |
Why?
|
Patient Selection | 1 | 2005 | 685 | 0.190 |
Why?
|
Myocardial Ischemia | 2 | 2005 | 162 | 0.190 |
Why?
|
Angioplasty, Balloon, Laser-Assisted | 2 | 1996 | 2 | 0.170 |
Why?
|
Middle Aged | 30 | 2013 | 25028 | 0.160 |
Why?
|
Intranuclear Inclusion Bodies | 1 | 2016 | 3 | 0.140 |
Why?
|
Promyelocytic Leukemia Protein | 1 | 2016 | 8 | 0.140 |
Why?
|
Hypertension, Pulmonary | 2 | 2005 | 346 | 0.140 |
Why?
|
Male | 34 | 2013 | 40965 | 0.130 |
Why?
|
Immunity, Innate | 1 | 2018 | 409 | 0.130 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2015 | 49 | 0.130 |
Why?
|
Virus Replication | 1 | 2016 | 319 | 0.130 |
Why?
|
Humans | 50 | 2018 | 86643 | 0.120 |
Why?
|
Surveys and Questionnaires | 2 | 2013 | 2501 | 0.120 |
Why?
|
Herpesvirus 1, Human | 1 | 2016 | 244 | 0.120 |
Why?
|
Aged | 18 | 2013 | 18415 | 0.110 |
Why?
|
Coronary Vasospasm | 2 | 1992 | 12 | 0.110 |
Why?
|
Female | 26 | 2013 | 44532 | 0.110 |
Why?
|
Genes, Viral | 1 | 2012 | 116 | 0.110 |
Why?
|
Adult | 23 | 2013 | 25648 | 0.110 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2012 | 133 | 0.110 |
Why?
|
DEAD-box RNA Helicases | 1 | 2012 | 62 | 0.110 |
Why?
|
Chromatography, Liquid | 1 | 2012 | 104 | 0.110 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 103 | 0.110 |
Why?
|
DNA, Complementary | 1 | 2012 | 393 | 0.110 |
Why?
|
Membrane Proteins | 1 | 2018 | 1196 | 0.100 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 268 | 0.100 |
Why?
|
Florida | 2 | 2011 | 55 | 0.100 |
Why?
|
Self Care | 1 | 2013 | 164 | 0.100 |
Why?
|
HeLa Cells | 1 | 2012 | 498 | 0.100 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 425 | 0.100 |
Why?
|
Myocardial Infarction | 3 | 1993 | 376 | 0.100 |
Why?
|
Personality Inventory | 1 | 2011 | 108 | 0.100 |
Why?
|
Cardiovascular Agents | 1 | 2011 | 56 | 0.100 |
Why?
|
Self Concept | 1 | 2011 | 133 | 0.100 |
Why?
|
Risk Factors | 4 | 2011 | 5417 | 0.090 |
Why?
|
MicroRNAs | 1 | 2015 | 534 | 0.090 |
Why?
|
Escherichia coli | 1 | 2012 | 597 | 0.090 |
Why?
|
Self Report | 1 | 2011 | 288 | 0.090 |
Why?
|
Medication Adherence | 1 | 2011 | 129 | 0.090 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 937 | 0.090 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 853 | 0.090 |
Why?
|
Ventricular Function, Left | 1 | 1993 | 592 | 0.090 |
Why?
|
Coronary Thrombosis | 1 | 1989 | 14 | 0.090 |
Why?
|
Cardiac Pacing, Artificial | 4 | 2005 | 87 | 0.080 |
Why?
|
Longitudinal Studies | 1 | 2011 | 1019 | 0.080 |
Why?
|
Emotions | 1 | 2011 | 341 | 0.080 |
Why?
|
Heart Ventricles | 10 | 2005 | 760 | 0.080 |
Why?
|
Prevalence | 1 | 2011 | 1239 | 0.070 |
Why?
|
Coronary Angiography | 7 | 2003 | 232 | 0.070 |
Why?
|
Electrocardiography | 15 | 1992 | 478 | 0.070 |
Why?
|
Treatment Outcome | 7 | 2011 | 7993 | 0.070 |
Why?
|
Sick Sinus Syndrome | 1 | 2005 | 9 | 0.070 |
Why?
|
Cardiac Output | 3 | 2005 | 156 | 0.070 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2005 | 97 | 0.060 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2005 | 108 | 0.060 |
Why?
|
Cardiotonic Agents | 1 | 2005 | 87 | 0.060 |
Why?
|
Oxygen Consumption | 2 | 2005 | 239 | 0.060 |
Why?
|
Serum Albumin | 1 | 2005 | 130 | 0.060 |
Why?
|
Survival Analysis | 2 | 2005 | 1538 | 0.060 |
Why?
|
Home Care Services | 1 | 2005 | 72 | 0.060 |
Why?
|
Creatinine | 1 | 2005 | 338 | 0.060 |
Why?
|
Waiting Lists | 1 | 2005 | 175 | 0.060 |
Why?
|
Heart Aneurysm | 1 | 2003 | 22 | 0.060 |
Why?
|
Coronary Stenosis | 1 | 2003 | 39 | 0.060 |
Why?
|
Leg | 1 | 2003 | 137 | 0.060 |
Why?
|
Heart Conduction System | 6 | 1978 | 108 | 0.060 |
Why?
|
Ventricular Remodeling | 1 | 2003 | 96 | 0.060 |
Why?
|
Heart Arrest | 4 | 1991 | 265 | 0.050 |
Why?
|
Acute Disease | 4 | 2005 | 826 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 1994 | 66 | 0.050 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2001 | 3 | 0.050 |
Why?
|
Holmium | 3 | 1996 | 3 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 4 | 1992 | 187 | 0.050 |
Why?
|
Sirolimus | 1 | 2002 | 169 | 0.050 |
Why?
|
Tacrolimus | 1 | 2002 | 373 | 0.050 |
Why?
|
Tissue and Organ Procurement | 1 | 2005 | 311 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 1673 | 0.050 |
Why?
|
Brain Diseases | 1 | 2001 | 180 | 0.050 |
Why?
|
Neoplasms | 1 | 2015 | 2898 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2005 | 1801 | 0.040 |
Why?
|
Chromosomal Instability | 1 | 2018 | 19 | 0.040 |
Why?
|
Mice | 3 | 2018 | 11352 | 0.040 |
Why?
|
Biomarkers | 1 | 2005 | 1718 | 0.040 |
Why?
|
Cardiac Surgical Procedures | 1 | 2003 | 462 | 0.040 |
Why?
|
Statistics as Topic | 3 | 2011 | 238 | 0.040 |
Why?
|
Coronary Vessel Anomalies | 2 | 1992 | 41 | 0.040 |
Why?
|
Cohort Studies | 1 | 2005 | 2767 | 0.040 |
Why?
|
Prognosis | 2 | 2005 | 3679 | 0.040 |
Why?
|
Heart | 6 | 1989 | 539 | 0.040 |
Why?
|
Homeostasis | 1 | 2018 | 409 | 0.040 |
Why?
|
Co-Repressor Proteins | 1 | 2016 | 18 | 0.040 |
Why?
|
Antigens, Nuclear | 1 | 2016 | 25 | 0.040 |
Why?
|
Graft Rejection | 1 | 2002 | 1065 | 0.040 |
Why?
|
Adolescent | 6 | 2005 | 8981 | 0.040 |
Why?
|
Vero Cells | 1 | 2016 | 100 | 0.040 |
Why?
|
Molecular Chaperones | 1 | 2016 | 111 | 0.030 |
Why?
|
Interferon-beta | 1 | 2016 | 125 | 0.030 |
Why?
|
Autoantigens | 1 | 2016 | 127 | 0.030 |
Why?
|
Tachycardia | 5 | 1980 | 35 | 0.030 |
Why?
|
Bioprosthesis | 2 | 1986 | 36 | 0.030 |
Why?
|
Heterografts | 1 | 2015 | 98 | 0.030 |
Why?
|
Heart Valve Prosthesis | 2 | 1986 | 93 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 187 | 0.030 |
Why?
|
Mice, SCID | 1 | 2015 | 252 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 302 | 0.030 |
Why?
|
Time Factors | 7 | 2005 | 5210 | 0.030 |
Why?
|
Diastole | 1 | 1993 | 144 | 0.030 |
Why?
|
Hemodynamics | 6 | 1989 | 710 | 0.030 |
Why?
|
Animals | 3 | 2018 | 26582 | 0.030 |
Why?
|
Angioplasty, Balloon | 1 | 1993 | 95 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2018 | 1578 | 0.030 |
Why?
|
Bundle of His | 5 | 1978 | 42 | 0.030 |
Why?
|
Laser Therapy | 1 | 1993 | 142 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2016 | 696 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2011 | 2705 | 0.020 |
Why?
|
Hostility | 1 | 2011 | 24 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 1056 | 0.020 |
Why?
|
Gene Expression | 1 | 2015 | 1284 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2003 | 6509 | 0.020 |
Why?
|
Regression Analysis | 1 | 2011 | 596 | 0.020 |
Why?
|
Psychometrics | 1 | 2011 | 327 | 0.020 |
Why?
|
Heart Rupture, Post-Infarction | 1 | 1989 | 7 | 0.020 |
Why?
|
Angina Pectoris, Variant | 1 | 1989 | 1 | 0.020 |
Why?
|
Heart Rupture | 1 | 1989 | 9 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 2426 | 0.020 |
Why?
|
Pacemaker, Artificial | 4 | 1977 | 87 | 0.020 |
Why?
|
Ventricular Fibrillation | 3 | 1980 | 65 | 0.020 |
Why?
|
Phenotype | 1 | 2015 | 2378 | 0.020 |
Why?
|
Wolff-Parkinson-White Syndrome | 2 | 1977 | 11 | 0.020 |
Why?
|
Comorbidity | 1 | 2011 | 943 | 0.020 |
Why?
|
Physical Exertion | 1 | 1986 | 39 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2011 | 394 | 0.020 |
Why?
|
Cardiac Catheterization | 6 | 1989 | 291 | 0.020 |
Why?
|
Airway Obstruction | 1 | 1986 | 109 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 1621 | 0.020 |
Why?
|
Aortic Valve Insufficiency | 1 | 1986 | 130 | 0.020 |
Why?
|
Bundle-Branch Block | 4 | 1978 | 48 | 0.020 |
Why?
|
Resuscitation | 2 | 1989 | 100 | 0.020 |
Why?
|
Follow-Up Studies | 5 | 2003 | 3640 | 0.020 |
Why?
|
Myocardial Revascularization | 2 | 1975 | 31 | 0.020 |
Why?
|
Propranolol | 2 | 1982 | 45 | 0.020 |
Why?
|
Heart Atria | 5 | 1977 | 250 | 0.020 |
Why?
|
Plethysmography | 1 | 2003 | 18 | 0.010 |
Why?
|
Compliance | 1 | 2003 | 23 | 0.010 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2003 | 73 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 2002 | 894 | 0.010 |
Why?
|
Oxyhemoglobins | 2 | 1980 | 31 | 0.010 |
Why?
|
Coronary Artery Bypass | 2 | 1975 | 228 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2003 | 2207 | 0.010 |
Why?
|
Arteries | 1 | 2003 | 176 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 1984 | 306 | 0.010 |
Why?
|
Shock, Cardiogenic | 1 | 2003 | 95 | 0.010 |
Why?
|
Cause of Death | 1 | 2003 | 277 | 0.010 |
Why?
|
Verapamil | 1 | 1982 | 48 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2002 | 235 | 0.010 |
Why?
|
Thoracic Injuries | 1 | 1981 | 32 | 0.010 |
Why?
|
Phialophora | 1 | 2001 | 1 | 0.010 |
Why?
|
Immunocompetence | 1 | 2001 | 27 | 0.010 |
Why?
|
Blood Coagulation | 1 | 1981 | 91 | 0.010 |
Why?
|
Atrial Fibrillation | 2 | 1992 | 288 | 0.010 |
Why?
|
ROC Curve | 1 | 2003 | 752 | 0.010 |
Why?
|
Cardiac Complexes, Premature | 2 | 1977 | 7 | 0.010 |
Why?
|
Heart Block | 2 | 1978 | 32 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2015 | 2903 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2003 | 349 | 0.010 |
Why?
|
Wounds, Nonpenetrating | 1 | 1981 | 92 | 0.010 |
Why?
|
Mycoses | 1 | 2001 | 46 | 0.010 |
Why?
|
Stroke Volume | 1 | 2003 | 456 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2003 | 999 | 0.010 |
Why?
|
Disease Progression | 1 | 2005 | 1531 | 0.010 |
Why?
|
Diatrizoate | 1 | 1980 | 15 | 0.010 |
Why?
|
Atrioventricular Node | 2 | 1978 | 33 | 0.010 |
Why?
|
Diatrizoate Meglumine | 1 | 1980 | 24 | 0.010 |
Why?
|
Emergencies | 1 | 1980 | 113 | 0.010 |
Why?
|
Incidence | 1 | 2003 | 1577 | 0.010 |
Why?
|
Unconsciousness | 1 | 1977 | 4 | 0.010 |
Why?
|
Atrial Flutter | 1 | 1977 | 33 | 0.010 |
Why?
|
Anti-Arrhythmia Agents | 1 | 1977 | 58 | 0.010 |
Why?
|
Tinnitus | 1 | 1977 | 21 | 0.010 |
Why?
|
Sinoatrial Node | 1 | 1976 | 10 | 0.010 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 1976 | 42 | 0.010 |
Why?
|
Radiography | 2 | 1994 | 813 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2003 | 8489 | 0.010 |
Why?
|
Myxoma | 1 | 1975 | 28 | 0.010 |
Why?
|
Contrast Media | 1 | 1980 | 1078 | 0.010 |
Why?
|
Heart Septum | 2 | 1989 | 45 | 0.010 |
Why?
|
Heart Neoplasms | 1 | 1975 | 62 | 0.010 |
Why?
|
Angiography | 2 | 1991 | 208 | 0.010 |
Why?
|
Mitral Valve | 2 | 1986 | 248 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1994 | 364 | 0.010 |
Why?
|
Ergonovine | 1 | 1992 | 2 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 1992 | 45 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 1992 | 203 | 0.010 |
Why?
|
Recurrence | 1 | 1994 | 1139 | 0.010 |
Why?
|
Pilot Projects | 1 | 1993 | 839 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 1992 | 232 | 0.010 |
Why?
|
Registries | 1 | 1994 | 702 | 0.010 |
Why?
|
Angina Pectoris | 2 | 1982 | 28 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 1992 | 351 | 0.010 |
Why?
|
Bradycardia | 2 | 1980 | 39 | 0.010 |
Why?
|
Echocardiography | 2 | 1989 | 911 | 0.010 |
Why?
|
Death, Sudden | 2 | 1980 | 40 | 0.000 |
Why?
|
Coronary Artery Disease | 1 | 1992 | 350 | 0.000 |
Why?
|
Electrophysiology | 2 | 1978 | 401 | 0.000 |
Why?
|
Heart Diseases | 1 | 1989 | 290 | 0.000 |
Why?
|
Endocarditis, Bacterial | 1 | 1986 | 33 | 0.000 |
Why?
|
Myocardium | 1 | 1989 | 529 | 0.000 |
Why?
|
Thromboembolism | 1 | 1986 | 119 | 0.000 |
Why?
|
Risk | 2 | 1977 | 674 | 0.000 |
Why?
|
Angiocardiography | 2 | 1975 | 31 | 0.000 |
Why?
|
Aortic Valve | 1 | 1986 | 222 | 0.000 |
Why?
|
Cineangiography | 1 | 1984 | 13 | 0.000 |
Why?
|
Age Factors | 1 | 1989 | 1851 | 0.000 |
Why?
|
Aortography | 1 | 1984 | 63 | 0.000 |
Why?
|
Child | 2 | 1986 | 6927 | 0.000 |
Why?
|
Prospective Studies | 1 | 1992 | 4213 | 0.000 |
Why?
|
Anticoagulants | 1 | 1986 | 408 | 0.000 |
Why?
|
Hospitalization | 2 | 1980 | 849 | 0.000 |
Why?
|
Equipment Failure | 1 | 1983 | 119 | 0.000 |
Why?
|
Graft Survival | 1 | 1986 | 884 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1983 | 109 | 0.000 |
Why?
|
Calcinosis | 1 | 1983 | 224 | 0.000 |
Why?
|
Reoperation | 1 | 1983 | 597 | 0.000 |
Why?
|
Erythrocyte Membrane | 1 | 1980 | 60 | 0.000 |
Why?
|
Femoral Artery | 1 | 1980 | 81 | 0.000 |
Why?
|
Pulmonary Embolism | 1 | 1981 | 222 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1980 | 493 | 0.000 |
Why?
|
Purkinje Fibers | 1 | 1978 | 27 | 0.000 |
Why?
|
Evaluation Studies as Topic | 1 | 1978 | 274 | 0.000 |
Why?
|
Arrhythmia, Sinus | 1 | 1977 | 7 | 0.000 |
Why?
|
Quinidine | 1 | 1977 | 11 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1982 | 1961 | 0.000 |
Why?
|
Diphosphoglyceric Acids | 1 | 1977 | 10 | 0.000 |
Why?
|
Lidocaine | 1 | 1977 | 63 | 0.000 |
Why?
|
Erythrocytes | 1 | 1977 | 255 | 0.000 |
Why?
|
Myocardial Contraction | 1 | 1977 | 244 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1977 | 181 | 0.000 |
Why?
|
Cardiomegaly | 1 | 1976 | 111 | 0.000 |
Why?
|
Monitoring, Physiologic | 1 | 1977 | 268 | 0.000 |
Why?
|
Mobile Health Units | 1 | 1975 | 11 | 0.000 |
Why?
|
Saphenous Vein | 1 | 1975 | 61 | 0.000 |
Why?
|
Vascular Resistance | 1 | 1975 | 102 | 0.000 |
Why?
|
Oxygen | 1 | 1980 | 726 | 0.000 |
Why?
|
Pulmonary Circulation | 1 | 1975 | 86 | 0.000 |
Why?
|
Transplantation, Autologous | 1 | 1975 | 331 | 0.000 |
Why?
|
Coronary Vessels | 1 | 1975 | 177 | 0.000 |
Why?
|
Chronic Disease | 1 | 1977 | 971 | 0.000 |
Why?
|
Blood Pressure | 1 | 1975 | 1143 | 0.000 |
Why?
|